HEPATIC CIRRHOSIS

Clinical trials for HEPATIC CIRRHOSIS explained in plain language.

Never miss a new study

Get alerted when new HEPATIC CIRRHOSIS trials appear

Sign up with your email to follow new studies for HEPATIC CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug AZD2389 targets scarred livers in tiny early trial

Knowledge-focused Ongoing

This early study tests whether a single dose of the experimental drug AZD2389 can attach to a protein called FAP in the liver. Twelve adults with advanced liver scarring (fibrosis) will get a PET scan before and after taking the drug to see if it binds to its target. The goal is …

Matched conditions: HEPATIC CIRRHOSIS

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Jul 02, 2026 03:00 UTC

HEPATIC CIRRHOSIS

Get alerted when new HEPATIC CIRRHOSIS trials appear

New drug AZD2389 targets scarred livers in tiny early trial